Simultaneous qualitative and quantitative metabolism data generation: a convenient marriage?

References

• 1  Li AC, Alton D, Bryant MS, Shou WZ. Simultaneously quantifying parent drugs and screening for metabolites in plasma pharmacokinetic samples using selected reaction monitoring information-dependent acquisition on a QTrap instrument. Rapid Commun. Mass Spectrom.19,1943–1950 (2005).
  Medline CASGoogle Scholar
• 2  Trunzer M, Faller B, Zimmerlin A. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC–MS/MS validation. J. Med. Chem.52,329–335 (2009).
  Medline CASGoogle Scholar
• 3  Shou WZ, Magis L, Li AC, Naidong W, Bryant MS. A novel approach to perform metabolite screening during the quantitative LC–MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer. J. Mass Spectrom.40,1347–1356 (2005).
  Medline CASGoogle Scholar
• 4  Gao H, Materne OL, Howe DL, Brummel CL. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap. Rapid Commun. Mass Spectrom.21,3683–3693 (2007).
  Medline CASGoogle Scholar
• 5  Yao M, Ma L, Humphreys WG, Zhu M. Rapid screening and characterization of drug metabolites using a multiple ion monitoring-dependent MS/MS acquisition method on a hybrid triple quadrupole-linear ion trap mass spectrometer. J. Mass Spectrom.43,1364–1375 (2008).
  Medline CASGoogle Scholar
• 6  Cruciani G, Carosati E, DeBoeck B et al. Metasite: understanding metabolism in human cytochromes from the perspective of the chemist. J. Med. Chem.48,6970–6979 (2005).
  Medline CASGoogle Scholar
• 7  Testa B, Balmat AL, Long A, Judson P. Predicting drug metabolism – an evaluation of the expert system METEOR. Chem. Biodivers.2,872–885 (2005).
  Medline CASGoogle Scholar
• 8  Kantharaj E, Tuytelaars A, Proost PEA, Ongel Z, van Assouw HP, Gilissen RA. Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry. Rapid Commun. Mass Spectrom.17,2661–2668 (2003).
  Medline CASGoogle Scholar
• 9  King RC, Gundersdorf R, Fernandez-Metzler CL. Collection of selected reaction monitoring and fullscan data on a time scale suitable for target compound quantitative analysis by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom.17,2413–2422 (2003).
  Medline CASGoogle Scholar
• 10  Hopfgartner G, Tonoli D, Varesio E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal. Bioanal. Chem.402(8),2587–2596 (2012).
  Medline CASGoogle Scholar
• 11  Korfmacher W. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures. Bioanalysis3,1169–1171 (2011).
  CASGoogle Scholar